|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 18,1997 PSA#1827Centers for Disease Control and Prevention (CDC), Procurement & Grants
Office, Contracts & Purchases Branch, 255 East Paces Ferry Rd, N.E, Rm
419, Atlanta, GA 30305 70 -- MVS-COMPATIBLE MAINFRAME PROCESSOR COMPLEX SOL 97-36 POC Sherry
Smallwood, Contract Specialist Correction: This action originally
publicized in the CBD dated 03/28/1997 is corrected as follows: (1)
Offerors are instructed to disregard the synopsis published in the CBD
on 04/03/1997 which modified the originally published
synopsis/solicitation, and the partial synopsis that was published in
the CBD on 04/04/1997 which resulted from a transmission error; (2) The
parallel channel data transfer rate may be up to 6.0 MPBS, but no less
than 4.5 MBPS, (3) Equipment will be acquired as either an initial
purchase or as a 36 month lease to ownership with option to purchase
prior to the end of the lease period. In addition to proposing 36 equal
monthly lease payments and a monthly purchase price factor for the base
system and all optional items, offerors must also propose an initial
purchase price for the base system and all optional items; (4) Award
will be made to the offeror whose proposal provides the greatest
overall value to the Government. Technical conformance and price are of
approximately equal value. Each evaluation factor will be evaluated
separately (technical conformance, past performance, price,
value-added) as follows: (a) TECHNICAL CONFORMANCE: Offers will be
evaluated on a pass/fail basis as to the conformance of the proposed
equipment with the minimum specifications identified in the original
synopsis dated 3/28/97, as amended; (b) PAST PERFORMANCE: Offers will
be assigned a risk assessment based on information that CDC obtains
from the offeror's past performance information. Risk assessment will
be a subjective rating (high, low, moderate) that will be used as a
separate evaluation factor; (c) PRICE: Offerors have been instructed to
submit pricing information for this equipment both as an initial
purchase and as a 36 month lease. If CDC elects to purchase the base
system and optional items, price analysis will be based on the sum of
the purchase price of the base system and the optional items. The
following evaluation factors will also be used in performing a price
analysis: (1) the exchange/sale price offered for CDC's existing IBM
ES/9000 9021-740, and (2) environmental costs (cents per kilowatt hour)
based on a 3-year ownership cycle. If CDC elects to purchase the base
system and lease the optional items, price analysis will be based on
the sum of (1) the purchase price of the base system, (2) the total of
the 36 month lease payments for the optional items, and (3) an average
of the cost to purchase the optional items over the life of the 36
months based on one month chosen in each of the three years. The
following evaluation factors will also be used in performing a price
analysis: (1) the exchange/sale price offered for CDC's existing IBM
ES/9000 9021-740, and (2) environmental costs (cents per kilowatt hour)
based on a 3-year ownership cycle. If CDC elects to lease the base
system and the optional items, price analysis will be based on the sum
of (1) the 36 month lease payments for the base system and optional
items, and (2) an average of the cost to purchase the base system and
optional items over the life of the 36 months, based on one month
chosen in each of the three years. The following evaluation factors
will also be used in performing a price analysis: (1) the exchange/sale
price offered for CDC's existing IBM ES/9000 9021-740, and (2)
environmental costs (cents per kilowatt hour) based on a 3-year
ownership cycle. (d) VALUE ADDED: Configuration will be considered to
have value-added if the uni-processor speed exceeds 47 MIPS, or if CDC
determines that other features, capabilities, or capacities of
proposed equipment enhance the performance of the equipment and provide
a specific benefit to CDC. A cost/technical trade-off analysis will be
conducted such that business judgement will be exercised in selecting
the most advantageous alternative to the Government, considering both
the technical merit and price of proposals. The determination of the
greatest overall value will be made by comparing the differences in the
value of performance capability factors for each value-added feature
with the differences in the prices proposed. The Government will not
make an award at a significantly higher overall price to achieve only
slightly superior performance capability features. (5) Proposals are
due by 2:00 PM EST no later than 10 days from the publication of this
announcement; and (6) Installation for the base system shall occur on
or about July 4, 1997. If necessary, the Government may delay the start
of the performance period, but such a delay shall not exceed 30
consecutive days. In addition to the above mentioned corrections,
offerors are hereby notified of the answers to the questions received
in response to the original synopsis. Question 1: The RFP states that
the processor complex must "have 32 parallel channels compatible with
IBM parallel channel protocol with data transfer rates up to 6.0 MBPS."
Since most controllers with parallel channels can only transfer data at
4.5 MB per second to and from the parallel channels, isn't it more
reasonable to require the data transfer rate for the parallel channels
to be at 4.5 MBPS instead of 6.0 MBPS? Answer 1: The CBD
synopsis/solicitation published on 03/28/97 requires a parallel channel
protocol with a data transfer rate of "up to 6.0 MBPS"; therefore,
offerors may propose data transfer rates of less than 6.0 MBPS.
However, since CDC's current parallel channel data transfer rate is 4.5
MBPS, offerors must propose a parallel channel data transfer rate with
a minimum of 4.5 MBPS. Question 2: As stated in the RFP,
"configuration proposed will be considered to have value-added if
uni-processor speed exceeds 47 MIPS or if other features, capabilities,
or capacities of proposed equipment provide specific benefits to CDC."
Since the offerors need to assess the trade-off between increasing
MIPS and increasing costs, would CDC please explain how these
value-adds will be evaluated, that is, how many points will be assigned
to the additional MIPS and other desirable features in the evaluation
process? Answer 2: See 4(d) above. Question 3: Normally, environmental
costs as well as maintenance charges are included in the life-cycle
system cost. Would CDC consider including both the environmental costs
and maintenance charges in the base period and five option years in
the price evaluation? If so, what factors will be used for
environmental costs, i.e. cents per kilowatt hour and dollars per
square foot? Answer 3: Proposed prices (both purchase and lease) must
represent a bundled price of the equipment and a 36 month maintenance
warranty. CDC will be using environmental costs as a price evaluation
factor. See 4(c) above for information regarding price evaluation.
Question 4: Please confirm that the Base Period will extend from time
of award through 9/30/97. Additionally, for evaluation purposes, can
CDC please identify specific month(s) for procuring the optional items
in the two option years? Answer 4: If the equipment is acquired as an
initial purchase, the base period will be from date of award through
06/30/1998, with the installation and Government acceptance occuring
during the month of July 1997. Option period 1 will be 07/01/1998 --
06/30/1999; option period 2 will be 07/01/1999 -- 06/30/2000; option
period 3 will be 07/01/2000 06/30/2001, and option period 4 will be
07/01/2001 -- 06/30/2002. The option periods will be used for the
acquisition of the optional line items (lease or purchase). If the
equipment is acquired as a 36 month lease, the base period will be from
date of award through 12 months after acceptance of the equipment by
the Government. The Government anticipates that installation and
Government acceptance will occur during the month of July 1997. Option
periods in the lease environment will be in 12 month increments
following the base period, and will be used to continue lease payments
as well as acquire the optional line items (purchase or lease). At
this time, CDC is unable to identify a specific month for procuring the
optional items. CDC anticipates that the optional items, if acquired,
will be purchased or leased during the first two option periods of the
contract. Offerors are required to submit pricing information on the
optional items for each of the first two option years, as described in
the original synopsis/solicitation that was published on 03/28/97.
Question 5: The RFP states that "equipment will be acquired through a
36 month lease to ownership which includes an option to purchase."
Please confirm that your intent is to own the equipment after 36
payments, i.e., 36 payments will result in payment in full and title
will pass to CDC (versus a true lease, which will result in balance due
after 36 payments, and an option to purchase at that time.) Answer 5:
If the equipment is acquired as a 36 month lease, it is the intention
of CDC to own the equipment after 36 payments (i.e., 36 payments will
result in payment in full and title will pass to CDC). The intention of
the "option to purchase" phrase is to allow for an option to purchase
the equipment prior to the end of the lease period in accordance with
Federal Acquisition Regulation (FAR) clause 52.207-5, Option to
Purchase. Question 6: Will CDC allow the use of indexed rates in the
lease to purchase plan for the optional items, which is to occur in
option year 1 or 2? This will be mutually beneficial to both the CDC
and the contractor. Answer 6: No. Question 7: Please confirm whether
the requirement remains firm for "equal" monthly payments. If yes, will
the CDC consider some form of return charge/termination payment should
the lease be canceled? If a return charge will be considered, how will
it be used in the evaluation process? Answer 7: Yes, the requirement
for equal monthly payments remains firm. If termination of this
contract is necessary, it will be handled in accordance with the
appropriate termination section of FAR clause 52.212-4, Contract Terms
and Conditions -- Commercial Items. Question 8: On past performance,
it is required to list all contracts currently in process that are
similar in size and complexity to this acquisition. This could result
in a lengthy unwieldy list for this bidder. Would CDC consider limiting
the number of contracts to, for example, 10 current Federal contracts?
Answer 8: Yes, offerors may limit current contract references to 10.
Question 9: Please specify the specific information required for the
list of contracts to be considered for past performance evaluation. For
example, the contract name/number, location, contact person, phone
number, technology/product, etc. of the contract. Answer 9: The
following information is required for each contract reference: (1) name
and address of customer/client or Government agency, (2) contract
number, (3) contract type, (4) total contract value, (5) description of
requirement, (6) Contracting Officer's name, address, and telephone
number, and (7) Project Officer's name, address, and telephone number.
Question 10: Your technical requirements state that parallel channels
must conform to IBM's channel protocol with data transfer rates of up
to 6.0 MBPS. The standard driven by OEM 370 Channel Interface or data
streaming is 3.0 and 4.5 respectively. We believe that only one
vendor, HDS, can meet the 6.0 MBPS requirement. If this is the case,
then there is effectively no competition for the CDC requirement, as
stated. We request that this requirement be changed to "up to 4.5
MBPS". Answer 10: See answer 1 above. Question 11: With minor changes
to your specification, the [vendor name and brand name of the processor
has been omitted from the question] would meet your requirement with a
highly competitive technical and cost solution. In this regard, we
request a meeting with the CDC in order to present the [brand name of
the processor has been omitted from the question] solution. Answer 11:
The synopsis/solicitation, as amended, reflects the minimum
requirements of CDC. The features that are desirable for CDC that are
above the minimum requirements have been identified as value-added
features. Offers that do not propose the value added features will not
be penalized. CDC will perform a cost/technical trade-off analysis on
the offers that do propose these features in order to make a
determination as to which offer provides the greatest overall value to
the Government. A meeting between a potential offeror and the
Government is not appropriate during this phase of the acquisition
process; however, offerors may submit an alternate commercial item
proposal in accordance with FAR clause 52.212-1, Instructions to
Offerors -- Commercial Items. Question 12: The RFP states that
"separate prices must be proposed for each item of equipment included
in the processor complex." This bidder would like to interpret 'each
item of equipment in the processor complex' as 'each separate box in
the processor complex', and NOT 'each feature in the box'. This is
because 1) not each feature in the box can be separately purchased; and
2) the features in the box cannot be financed separately. Answer 12:
Your interpretation is correct. Offerors are to submit separate pricing
for each separate box in the processor complex, and not each separate
feature. All other information publicized in the original synopsis is
correct. MMMM (0106) Loren Data Corp. http://www.ld.com (SYN# 0295 19970418\70-0008.SOL)
70 - General Purpose ADP Equipment Software, Supplies and Support Eq. Index Page
|
|